Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on PCSK9 inhibitors for calcific aortic stenosis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PCSK9 inhibitors

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Aortic Stenosis, Calcific | Phase 3 | Status: NOT_YET_RECRUITING